SYNBIOTIC SE

News

14.08.2025 11:19:43
EQS-News: Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
29.07.2025 12:54:04
EQS-News: Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
11.06.2025 11:48:45
EQS-News: Successful roadshow continues: SYNBIOTIC keeps expanding its presence in the cannabis and hemp industry
23.04.2025 09:24:43
EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Lending (free of charge) of 50,000 shares as part of a securities lending programme.
17.04.2025 14:14:23
EQS-News: IRIS Capital invests in SYNBIOTIC's growth strategy
01.04.2025 15:13:28
EQS-News: SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
13.03.2025 11:14:06
EQS-News: Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin
10.01.2025 11:44:28
EQS-News: SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025
18.12.2024 13:06:47
EQS-News: Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis
18.12.2024 09:01:01
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY

Downloads

Latest Research
Initiation

Analyst

Christian Sandherr

Equity Research

MailLinkedIn

Latest Research

Christian Sandherr

18 Dec 24

The new group continues to take shape; chg. est.

Update
Christian Sandherr

17 Sep 24

SynBiotic transformation: Reaching new operational high(t)s

Initiation
Christian Sandherr

29 Aug 23

Gearing up to capitalize on favorable market dynamics; chg.

Update
Christian Sandherr

28 Dec 22

Strategic realignment to capitalize on cannabis legalization; chg.

Update

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.